Cite
HARVARD Citation
Debieuvre, D. et al. (2021). Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada. Lung cancer. pp. 40-47. [Online].